Literature DB >> 26316513

Beneficial and detrimental role of adenosine signaling in diseases and therapy.

Hong Liu1, Yang Xia2.   

Abstract

Adenosine is a major signaling nucleoside that orchestrates cellular and tissue adaptation under energy depletion and ischemic/hypoxic conditions by activation of four G protein-coupled receptors (GPCR). The regulation and generation of extracellular adenosine in response to stress are critical in tissue protection. Both mouse and human studies reported that extracellular adenosine signaling plays a beneficial role during acute states. However, prolonged excess extracellular adenosine is detrimental and contributes to the development and progression of various chronic diseases. In recent years, substantial progress has been made to understand the role of adenosine signaling in different conditions and to clarify its significance during the course of disease progression in various organs. These efforts have and will identify potential therapeutic possibilities for protection of tissue injury at acute stage by upregulation of adenosine signaling or attenuation of chronic disease progression by downregulation of adenosine signaling. This review is to summarize current progress and the importance of adenosine signaling in different disease stages and its potential therapeutic effects.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  adenosine signaling; disease; hypoxia; therapy

Mesh:

Substances:

Year:  2015        PMID: 26316513      PMCID: PMC4839494          DOI: 10.1152/japplphysiol.00350.2015

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  137 in total

1.  Increased plasma adenosine concentrations and the severity of preeclampsia.

Authors:  Yoshio Yoneyama; Shunji Suzuki; Rintaro Sawa; Koichi Yoneyama; Gordon G Power; Tsutomu Araki
Journal:  Obstet Gynecol       Date:  2002-12       Impact factor: 7.661

2.  Adenosine A2A receptors in diffuse dermal fibrosis: pathogenic role in human dermal fibroblasts and in a murine model of scleroderma.

Authors:  E S L Chan; P Fernandez; A A Merchant; M C Montesinos; S Trzaska; A Desai; C F Tung; D N Khoa; M H Pillinger; A B Reiss; M Tomic-Canic; J F Chen; M A Schwarzschild; B N Cronstein
Journal:  Arthritis Rheum       Date:  2006-08

3.  Extracellular adenosine induces apoptosis of human arterial smooth muscle cells via A(2b)-purinoceptor.

Authors:  M L Peyot; A P Gadeau; F Dandré; I Belloc; F Dupuch; C Desgranges
Journal:  Circ Res       Date:  2000 Jan 7-21       Impact factor: 17.367

Review 4.  Coffee and health: a review of recent human research.

Authors:  Jane V Higdon; Balz Frei
Journal:  Crit Rev Food Sci Nutr       Date:  2006       Impact factor: 11.176

5.  Adenosine A(2A) receptors mediate coronary microvascular dilation to adenosine: role of nitric oxide and ATP-sensitive potassium channels.

Authors:  T W Hein; L Belardinelli; L Kuo
Journal:  J Pharmacol Exp Ther       Date:  1999-11       Impact factor: 4.030

6.  A protective role for the A1 adenosine receptor in adenosine-dependent pulmonary injury.

Authors:  Chun-Xiao Sun; Hays W Young; Jose G Molina; Jonathan B Volmer; Jurgen Schnermann; Michael R Blackburn
Journal:  J Clin Invest       Date:  2005-01       Impact factor: 14.808

7.  The effects of selective A1 and A2a adenosine receptor antagonists on cerebral ischemic injury in the gerbil.

Authors:  J W Phillis
Journal:  Brain Res       Date:  1995-12-24       Impact factor: 3.252

8.  Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A2A receptor agonist regadenoson.

Authors:  Joshua J Field; Gene Lin; Maureen M Okam; Elaine Majerus; Jeffrey Keefer; Onyinye Onyekwere; Ainsley Ross; Federico Campigotto; Donna Neuberg; Joel Linden; David G Nathan
Journal:  Blood       Date:  2013-02-01       Impact factor: 22.113

9.  Adenosine2A receptors and epoxyeicosatrienoic acids: a recipe for salt and blood pressure regulation.

Authors:  John D Imig
Journal:  Hypertension       Date:  2009-10-12       Impact factor: 10.190

10.  Physiological roles for ecto-5'-nucleotidase (CD73).

Authors:  Sean P Colgan; Holger K Eltzschig; Tobias Eckle; Linda F Thompson
Journal:  Purinergic Signal       Date:  2006-06-01       Impact factor: 3.765

View more
  23 in total

Review 1.  Tumor-resident adenosine-producing mesenchymal stem cells as a potential target for cancer treatment.

Authors:  Samaneh Arab; Akram Alizadeh; Samira Asgharzade
Journal:  Clin Exp Med       Date:  2021-01-23       Impact factor: 3.984

Review 2.  Metabolomic and molecular insights into sickle cell disease and innovative therapies.

Authors:  Morayo G Adebiyi; Jeanne M Manalo; Yang Xia
Journal:  Blood Adv       Date:  2019-04-23

3.  Elevated ecto-5'-nucleotidase: a missing pathogenic factor and new therapeutic target for sickle cell disease.

Authors:  Hong Liu; Morayo Adebiyi; Rong Rong Liu; Anren Song; Jeanne Manalo; Yuan Edward Wen; Alexander Q Wen; Tingting Weng; Junsuk Ko; Modupe Idowu; Rodney E Kellems; Holger K Eltzschig; Michael R Blackburn; Harinder S Juneja; Yang Xia
Journal:  Blood Adv       Date:  2018-08-14

4.  Beneficial Role of Erythrocyte Adenosine A2B Receptor-Mediated AMP-Activated Protein Kinase Activation in High-Altitude Hypoxia.

Authors:  Hong Liu; Yujin Zhang; Hongyu Wu; Angelo D'Alessandro; Gennady G Yegutkin; Anren Song; Kaiqi Sun; Jessica Li; Ning-Yuan Cheng; Aji Huang; Yuan Edward Wen; Ting Ting Weng; Fayong Luo; Travis Nemkov; Hong Sun; Rodney E Kellems; Harry Karmouty-Quintana; Kirk C Hansen; Bihong Zhao; Andrew W Subudhi; Sonja Jameson-Van Houten; Colleen G Julian; Andrew T Lovering; Holger K Eltzschig; Michael R Blackburn; Robert C Roach; Yang Xia
Journal:  Circulation       Date:  2016-08-02       Impact factor: 29.690

Review 5.  Purinergic Signalling: Therapeutic Developments.

Authors:  Geoffrey Burnstock
Journal:  Front Pharmacol       Date:  2017-09-25       Impact factor: 5.810

6.  Myeloid Cell-Derived TGFβ Signaling Regulates ECM Deposition in Mammary Carcinoma via Adenosine-Dependent Mechanisms.

Authors:  Georgii Vasiukov; Tatiana Novitskaya; Andries Zijlstra; Philip Owens; Fei Ye; Zhiguo Zhao; Harold L Moses; Timothy Blackwell; Igor Feoktistov; Sergey V Novitskiy
Journal:  Cancer Res       Date:  2020-04-20       Impact factor: 12.701

7.  A metabolomic, geographic, and seasonal analysis of the contribution of pollen-derived adenosine to allergic sensitization.

Authors:  Geoffrey A Mueller; Peter M Thompson; Eugene F DeRose; Thomas M O'Connell; Robert E London
Journal:  Metabolomics       Date:  2016-11-02       Impact factor: 4.290

8.  The role of adenosine 1a receptor signaling on GFR early after the induction of sepsis.

Authors:  Jonathan M Street; Erik H Koritzinsky; Tiffany R Bellomo; Xuzhen Hu; Peter S T Yuen; Robert A Star
Journal:  Am J Physiol Renal Physiol       Date:  2017-11-08

Review 9.  Role of purines in regulation of metabolic reprogramming.

Authors:  Zhenwei Tang; Wenrui Ye; Haotian Chen; Xinwei Kuang; Jia Guo; Minmin Xiang; Cong Peng; Xiang Chen; Hong Liu
Journal:  Purinergic Signal       Date:  2019-09-06       Impact factor: 3.765

10.  Adenosine, Via A2B Receptors, Inhibits Human (P-SMC) Progenitor Smooth Muscle Cell Growth.

Authors:  Raghvendra K Dubey; Isabella Baruscotti; Ruth Stiller; Juergen Fingerle; Delbert G Gillespie; Zaichuan Mi; Brigitte Leeners; Bruno Imthurn; Marinella Rosselli; Edwin K Jackson
Journal:  Hypertension       Date:  2019-12-02       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.